Pliant Therapeutics Announces Positive Safety and
Bexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; No safety concerns...
Source: globenewswire.com
Mayo Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mayo Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mayo Score Today - Breaking & Trending Today
IBD: Saffron supplements may lower inflammation in ulcerative colitis
Adding saffron supplements to standard-of-care treatment for ulcerative colitis may help reduce inflammation and positively benefit patients, a new study indicates.
Source: medicalnewstoday.com
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Bexotegrast was well tolerated over 12 weeks of treatment with few discontinuations and no drug-related severe or serious adverse events Bexotegrast reduced both the Enhanced Liver Fibrosis ...
Source: marketscreener.com
Pliant Therapeutics Announces Positive Safety and
Bexotegrast (PLN-74809) was well tolerated over 12 weeks of treatment with few discontinuations and no drug-related severe or serious adverse events ...
Source: globenewswire.com
Ulcerative Colitis in Adults: A Review | Gastroenterology | JAMA
This review discusses the epidemiology, pathophysiology, diagnosis, and treatment of ulcerative colitis in adults.
Source: jamanetwork.com